Efficacy of botulinum toxin type a treatment of functional impairment of degenerative hip joint: Preliminary results

Corrado Marchini, Michele Acler, Marco A. Bolognari, Araldo Causero, Daniele Volpe, Dario Regis, Alessandra Rizzo, Raffaella Rosa, Roberto Eleopra, Paolo Manganotti

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: The aim of this study was to investigate the effect of botulinum toxin type A injection into the adductor muscles in reducing pain and improving joint mobility and quality of life in patients affected by hip osteoarthritis. Methods: A total of 39 outpatients, mean age 68 years (age range 41-82 years), were evaluated using the Harris Hip Score to test hip function, a visual analogue scale to measure pain intensity and the Short Form 36 (SF-36) questionnaire to assess patient well-being and quality of life at baseline, 2, 4 and 12 weeks after treatment with botulinum toxin type A. A total of 400 U of botulinum toxin type A (Dysport) was injected into the adductor longus muscle and the adductor magnus muscle. Results: The Harris Hip Score increased significantly after 2, 4 and 12 weeks (df 3, χ2 = 45.1; p2 = 27.8;/>

Original languageEnglish
Pages (from-to)691-693
Number of pages3
JournalJournal of Rehabilitation Medicine
Volume42
Issue number7
DOIs
Publication statusPublished - Jul 2010

Keywords

  • Botulinum toxin
  • Hip osteoarthritis
  • Muscle
  • Pain

ASJC Scopus subject areas

  • Rehabilitation
  • Physical Therapy, Sports Therapy and Rehabilitation
  • Medicine(all)

Fingerprint Dive into the research topics of 'Efficacy of botulinum toxin type a treatment of functional impairment of degenerative hip joint: Preliminary results'. Together they form a unique fingerprint.

Cite this